ArticleFrontiers in pharmacology2022

A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma.

Da Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.